Successful neridronate therapy in transient osteoporosis of the hip

Giovanni La Montagna; Domenico Malesci; Rosella Tirri; Gabriele Valentini

doi:10.1007/s10067-004-0957-9

Successful neridronate therapy in transient osteoporosis of the hip

Clin Rheumatol. 2005 Feb;24(1):67-9. doi: 10.1007/s10067-004-0957-9. Epub 2004 Aug 19.

Authors

Giovanni La Montagna¹, Domenico Malesci, Rosella Tirri, Gabriele Valentini

Affiliation

¹ Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale F Magrassi & A Lanzara, Seconda Università degli Studi di Napoli, Napoli, Italy. giovanni.lamontagna@unina2.it

PMID: 15322945
DOI: 10.1007/s10067-004-0957-9

Abstract

We report on an uncommon case of bilateral transient osteoporosis of the hip (TOH) occurring in a young woman during pregnancy. The clinical features and the therapeutic action of intramuscular neridronate sodium, a third-generation amino-bisphosphonate, are underlined.

Publication types

Case Reports

MeSH terms

Adult
Arthrography
Diphosphonates / administration & dosage
Diphosphonates / therapeutic use*
Female
Follow-Up Studies
Hip Joint* / diagnostic imaging
Hip Joint* / pathology
Humans
Injections, Intramuscular
Magnetic Resonance Imaging
Osteoporosis / diagnosis
Osteoporosis / drug therapy*
Tomography, Emission-Computed, Single-Photon
Treatment Outcome

Substances

Diphosphonates
6-amino-1-hydroxyhexane-1,1-diphosphonate